Enzo Biochem, Inc.
ENZ
$0.464
-$0.015-3.13%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 74.77% | -343.08% | 1.34% | 53.73% | -111.52% |
| Total Depreciation and Amortization | -19.85% | 18.10% | 26.22% | -1.11% | -55.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -87.14% | 177.39% | 422.22% | -115.59% | 103.11% |
| Change in Net Operating Assets | -175.58% | 691.80% | 75.23% | 39.46% | -305.13% |
| Cash from Operations | -728.57% | 62.09% | 67.98% | 33.17% | 21.47% |
| Capital Expenditure | -264.23% | 13.99% | -472.00% | 90.16% | 55.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 3,800.81% | 13.99% | -472.00% | 90.16% | -100.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 98.97% | -9,654.05% | -68.18% | 56.86% | 99.75% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 100.00% | -- | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 94.46% | -8,102.27% | -100.00% | 95.75% | 87.78% |
| Foreign Exchange rate Adjustments | -93.75% | 188.89% | -289.47% | 195.00% | 87.10% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.11% | -55.11% | 65.59% | 36.71% | -117.77% |
